We have added five totally new classes of non-insulin medications for the treatment of diabetes and so sometimes the reasons to even try insulin make no sense to many of us. However, when we identify patients that have severe cases of glucotoxicity and/or lipotoxicity we often find that they will …
Read More »Diabetes In Control
Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Much of the impact of chronic diabetes results from the development of tissue complications, mainly microvascular (retinopathy, nephropathy and neuropathy) and macrovascular disease (atherosclerosis). Microangiopathy is characterized by progressive occlusion of the capillary lumen with subsequent impaired tissue perfusion, increased vascular …
Read More »Editor’s Note, DCMS #210
This past weekend I was in Lexington, Kentucky to visit my father and sisters. While I was there, I saw a commercial for a heart institute and they mentioned that heart disease was the number one killer in America today. I would have to agree that many people die of …
Read More »ACO Performance Measures and Results
ACO Performance Measures and Results Of the 32 original Pioneer ACO participants, nine dropped out after the first year and another four have dropped out for this year citing increased costs of care as a reason. While these plans had losses in the first year of as much as …
Read More »ACO Update
After two years, only 19 of original 32 CMS Pioneer ACO’s still participating. See this week’s Tool for Your Practice and Letter from the Editor.
Read More »Letter from the Editor, #750: ACO Update
Two years ago the Affordable Care Act brought about the beginning of ACO’s (accountable care organizations). These organizations were created to bring quality of care into play for patients and to reward the best care providers with financial incentives. CMS wanted to prove the value of these ACO’s and so …
Read More »ITCA650 -12 month Dose GLP-1 Treatment
ITCA 650 A 1 year implant dose of exenatide in type 2 diabetes shows positive results. See item #6 for more information. See more GLP-1 Agonist Resources
Read More »Wider Diabetes Screening Needed
Draft recommendations from the USPSTF call for diabetes and blood glucose screening for people 45 and older and younger adults with risk factors. The guidelines, updated from 2008, are similar to those made by other medical groups and include recommendations for diet and exercise interventions for at-risk patients. The new …
Read More »Interventions to Prevent Development of Diabetes
As diabetes develops, we currently waste the first ∼10 years of the natural history. If we found prediabetes and early diabetes when they first presented and treated them more effectively, we could prevent or delay the progression of hyperglycemia and the development of complications. Evidence for this comes from trials …
Read More »Egg-rich Diet Safe for Diabetes Patients
Type 2 diabetes patients who followed an egg-rich diet did not show worse lipid levels than those who had lower egg consumption, according to research presented at the EASD meeting. Data also showed that an egg-rich diet was tied to better appetite control and satiety at three months. The study …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.